Funds will accelerate commercialization of InVisionFirstTM-Lung Liquid Biopsy test and the development of the InVision® liquid biopsy platform into new indications
Research Triangle Park, NC and Cambridge, UK, March 28, 2019 -- Inivata, a leader in liquid biopsy, today announces the completion of a Series B fundraising of $52.6m (£39.8 million).